Regulation of lipolysis in humans. Pathophysiological modulation in obesity diabetes, and hyperlipidaemia

Diabetes and Metabolism

Volumn 24, Issue 5, 1998, Pages 409-418

  Large, V ^a   Arner, P ^b  

^a INSERM   (France)

^b NONE

Author keywords

Adipose tissue; Adrenoceptor; Free fatty acids; Hormone sensitive lipase; Triglycerides

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE; CHOLECYSTOKININ; FATTY ACID; GLUCAGON; GROWTH HORMONE; HYDROCORTISONE; PARATHYROID HORMONE; SEX HORMONE; THYROID HORMONE; THYROTROPIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

BODY FAT; DIABETES MELLITUS; GLUCONEOGENESIS; HORMONAL REGULATION; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID STORAGE; LIPOLYSIS; LIPOPROTEIN SYNTHESIS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; REVIEW;

EID: 0031647224     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lip Res, 1994, 35, 177-193.
2. Renold AE, Cahill GF, eds. Section 5, Adipose tissue. Handbook of Physiology, Washington : American Physiological Society, 1965.
3. Arner P. Regulation of lipolysis in fat cells. Diabetes Rev, 1996, 4, 450-463.
4. Kissebah AH, Krakower GR. Regional Adiposity and Morbidity. Physiological Rev, 1994, 74, 761-811.
5. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 1996, 45, 3-10.
6. Arner P, Östman J. Mono- and diacylglycerol in human adipose tissue. Biochim Biophys Acta, 1974, 369, 209-211.
7. Edens NK, Leibel RL, Hirsch J. Mechanism of free fatty acid reesterification in human adipocytes in vitro. J Lip Res, 1990, 31, 1423-1431.
8. Langin D, Holm C, Lafontan M. Adipocyte hormone-sensitive lipase : a major regulator of lipid metabolism. Proceed Nutr Soc, 1996, 55, 93-109.
9. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lip Res, 1993, 34, 1057-1091.
10. Strålfors P, Belfrage P. Phosphorylation of hormone-sensitive-lipase by cyclic AMP-dependent protein kinase. J Biol Chem, 1983, 258, 15146-15152.
11. Tornqvist H, Beifrage P. Purification and some properties of a monoacylglycerol hydrolyzing enzyme of rat adipose tissue. J Biol Chem, 1976, 251, 813.
12. Degerman E, Belfrage P, Manganiello VC. Structure and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem, 1997, 272, 6823-6826.
13. Scow RO, Blanchette-Mackie EJ. Why fatty acids flow in cell membranes. Prog Lipid Res, 1985, 24, 197-241.
14. Abumrad NA, Melki SA, Harmon CM. Transport of fatty acids in isolated rat adipocyte and in differentiating preadipose cells. Biochem Soc Trans, 1991, 18, 1130-1132.
15. Potter BJ, Sorrentino D, Brek PD. Mechanism of cellular uptake of free fatty acids. Annu Rev Nutr, 1989, 9, 253-270.
16. Frayn KN, Humphreys SM, Coppack SW. Fuel selection in white adipose tissue. Proc Nutr Soc. 1995, 54, 177-189.
17. Meisner H, Carter JR. Regulation of lipolysis in adipose tissue. Horiz Biochem Biophys, 1977, 4, 91-129.
18. Enocksson S, Schimizu M, Lönnqvist F, Nordenström J, Arner P. Demonstration of an in vivo functional β3-adrenoceptor in man. J Clin Invest, 1995, 95, 2239-2245.
19. Hansen O, Johansson BW, Nilsson-Ehle P. Metabolic, electrophoretic and hemodynamic responses to increased circulating adrenaline : effects of selective and nonselective β-adrenoceptor blockade. Angiology, 1990, March, 175-188.
20. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral adenosine concentration in subcutaneous tissue in humans. J Clin Invest, 1995, 95, 1109-1116.
21. Marcus C, Ehreen H, Bolme P, Arner P. Regulation of lipolysis during the neonatal period. J Clin Invest, 1988, 82, 1793-1797.
22. Carlson MG, Snead WL, Campbell PJ. Regulation of free fatty acid metabolism by glucagon. J Clin Endocrinol Metab, 1993, 77, 11-15.
23. Richter WO, Schwandt P. Cholecystokinin 1-21 stimulates lipolysis in human adipose tissue. Horm Metab Res, 1989, 27, 216-217.
24. Taniguchi A, Kataoka K, Konto T, et al. Parathyroid hormone-induced lipolysis in human adipose tissue. J lip Res, 1987, 28, 490-494.
25. Ligget SB, Shah SD, Cryer PE. Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J Clin Invest, 1989, 83, 803-809.
26. Hellström L, Wahrenberg H, Reynisdottir S, Arner P. Catecholamines induced lipolysis in human hyperthyroidism. J Clin Endocrinol Metab, 1997, 82, 159-166.
27. Marcus C, Bolme P, Micha-Johansson G, Margery V, Bronnegard M. Growth hormone increases the lipolytic sensitivity for cathecholamines in adipocytes from healthy adults. Life sciences, 1994, 54, 1335-1341.
28. Boyle PJ, Avogaro A, Smith L, et al. Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans. Am J physiol, 1992, 263, E168-E172.
29. Heiling VJ, Jensen MD. Free fatty acid metabolism in the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab, 1992, 74, 806-810.
30. Björntorp P. Fatty acids, hyperinsulinemia and insulin resistance : Which comes first ? Current Opinion in Lipidology, 1994, 5, 166-174.
31. Ek I, Arner P, Bergqvist A, Carlstrom K, Wahrenberg H. Impaired adipocyte lipolysis in nonobcse women with the polycystic ovary syndrome : a possible link to insulin resistance ? J Clin Endocrinol Metab, 1997, 82, 1147-1153.
32. Stames F, Warren RS, Jeevanandam M, et al. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest, 1988, 82, 1321-1325.
33. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J. Effects of tumor necrosis factor alpha (TNF-α) on glucose transport and lipid metabolism of newly-differentiated human cell culture. Diabetologia, 1995, 38, 764-771.
34. Coppack SW, Frayn SM, Humphreys HD, Hockaday TDR. Effects of insulin on human adipose tissue metabolism in vivo. Clin Sc, 1989, 77, 663-670.
35. Cheatman B, Kahn R. Insulin action and the insulin signalling network. Endocrine Rev, 1995, 16, 117-142.
36. Lönnroth P, Smith U. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase. Biochem Biophys Res Com, 1986, 141, 1157-1161.
37. Hagström-Toft E, Bolinder J, Eriksson S, Aner P. Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo. Diabetes, 1995, 44, 1170-1175.
38. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem, 1994, 269, 3568-3573.
39. Strålfors P, Olsson H, Belfrage P. Insulin-induced dephosphorylation of hormone-sensitive lipase. Eur J Biochem, 1989, 182, 379-385.
40. Illiano G, Cuatrecasas P. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin. Science, 1972,175, 906-908.
41. Engfeldt P, Hellmer J, Wahrenberg H, Arner P. Effects of insulin on adrenoceptor binding and the role of catecholamine-induced lipolysis in isolated human fat cells. J Biol Chem, 1988, 263, 15553-15560.
42. Lafontan M, Bousquet-Melou A, Galitzky J, et al. Adrenergic receptors and fat cells : Differential recruitment by physiological amines and homologous regulation. Obesity Research, 1995, 3, 507S-514S.
43. Lafontan M, Berlan M. Fat cell a2-adrenoceptors : The regulation of fat cell function and lipolysis. Endocrine Rev, 1995, 16, 716-738.
44. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor 1 on glucose, lipid, and amino acid metabolism. Am J Physiol, 1992, 262, E130-E133.
45. Lönnroth P, Jansson PA, Fredholm BB, Smith U. Microdialysis of intracellular adenosine concentration in subcutaneous tissue in humans. Am J Physiol, 1989, 256, E250-E255.
46. Kather H. Purine accumulation in human fat cell suspensions. J Biol Chem, 1988, 263, 8803-8809.
47. Green A, Swenson S, Johnson JL, Partin M. Characterization of human adipocyte adenosine receptors. Biochem Biophys Res Commun, 1989, 163, 137-142.
48. Arner P. Adenosine, prostaglandins and phosphodiesterase as targets for obesity pharmacotherapy. Int J Obes, 1993, 17, S57-S59.
49. Richelsen B, Eriksen EF, Beck-Nielsen H, Pederson O. Prostaglandin E2 receptor binding and action in human fat cells. J Clin Endocrinol Metab, 1984, 59, 7-12.
50. Richelsen B. Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukotrienes & Essential Fatty Acids, 1992, 47, 171-182.
51. Valet P, Berlan M, Beauville M, Crampes F, Montastruc JL, Lafontan M. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J clin Invest, 1990, 85, 291-295.
52. Cannon B, Nedergaard J, Lundberg J, Hokfelt T, Teresius L, Goldstein M. Neuropeptide tyrosine (NPY) is costored with noradrenaline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. Exp Cell Res, 1986, 164, 546-550.
53. 1 in mammal adipocytes. Am J Physiol, 1994, 266, R1141-R1147.
54. Silverberg JD, Miles JM. Effect of ketosis on fatty acid and glucose kinetics [Abstract]. Clin Res, 1992, 40, 166A.
55. Coppack SW, Miles JM. Ketone body metabolism by human adipose tissue [Abstract]. Diabetologia, 1992, 35, A8.
56. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diab Metab Rev, 1988, 4, 507-515.
57. Andersson K, Arner P. Cholinoceptor-mediated effects on glycerol output from human adipose tissue using in situ microdialysis. Br J Pharmacol, 1995, 115, 1155-1162.
58. Leibel RL, Edens NK, Fried SK. Physiologic basis for the control of body fat distribution in humans. Annu Rev Nutr, 1989, 9, 417-443.
59. Bolinder J, Kager L, Östman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes, 1983, 32, 117-123.
60. 1-antagonists. J Lipid Res, 1988, 29, 587-601.
61. Arner P, Hellström L, Wahrenberg H, Brönnegard M. Beta-adrenoceptor expression in human fat cells fron different regions. J Clin Invest, 1990, 86, 1595-1600.
62. Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine LJ, Arner P. Evidence for a functional β3-adrenergic receptor in man. Br J Pharβ macol, 1993, 110, 929-936.
63. Wahrenberg H, Engfeldt P, Bolinder J, Arner P. Acute adaptation in adrenergic control of lipolysis during exercice in man. Am J Physiol, 1986, 253, E383-E390.
64. Marcus C, Karpe B, Bolme P, Sonnenfeld T, Arner P. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. J Clin Invest, 1987, 79, 1812-1818.
65. Marcus C, Sonnenfeld T, Karpe B, Bolme P, Arner P. Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults. Pediatr Res, 1989, 26, 255-259.
66. Marcus C, Ehren H, Bolme P, Arner P. Regulation of lipolysis during the neonatal period : importance of thyrotropin. J Clin Invest, 1988, 82, 1793-1797.
67. Lönnqvist F, Nyberg B, Whrenberg H, Arner P. Catecholamine-induced lipolysis in adipose tissue of the elderly. J Clin Invest, 1990, 85, 1614-1621.
68. Jansson PA, Larsson A, Smith U, Lonnroth P. Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest, 1992, 89, 1610-1617.
69. Bougneres P, Le Stunff C, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest, 1997, 99, 2568-2573.
70. Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, and Arner P. Catccholamine resistance in fat cells of women with upper-obesity due to increased expression of β2-adrenoceptors. Diahelologia, 1994, 37, 428-435.
71. Reynisdottir S, Langin D, Carlström K, Holm C, Rössner S, and Arner P. Effect of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clinical Science, 1995, 89, 421-429.
72. Lönnqvist F, Thome A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arteriosel Thromb Vasc Biol, 1997, 17, 1472-1480.
73. Björntorp P. Etiology of the metabolic syndrome. In : Bray GA, Bouchard C, James WPT, eds. « Handbook of obesity », New York : M. Dekker, 1998, 573-600.
74. Hagstrom-Toft E, Bolinder J, Ungerstedt U, Arner P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia, 1997, 40, 1070-1078.
75. Tchernof A, Lamarche B, Prud'Homme D, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care, 1996, 19, 629-637.
76. Arner P, Wahrenberg H, Lönnqvist F, Angclin B. Adipocyte β-adrenoceptor sensitivity influences plasma lipid levels. Arteriosclerosis and Thrombosis, 1993, 13, 967-972.
77. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state fot lipoprotein lipase deficiency. Arteriosclerosis, 1989, 8, 326-334.
78. Cianflone KM, Maslowska MH, Sniderman AD. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. J Clin Invest, 1990, 85, 722-730.
79. Reynisdottir S, Eriksson M, angelin B, Arner P. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J clin Invest, 1995, 95, 2161-2169.
80. Bouchard C. Inheritance of fat distribution and adipose tissue metabolism. In : Vague J, Björntorp P, Guy-Grant B, eds. « Metabolic complications of human obesities », Amsterdam : Elsevier Science Publishers, 1985, 87-96.
81. Bouchard C. Genetic factor in the regulation of adipose tissue distribution. Acta Med Scand, 1988, 723, 135-141.
82. Poehlman ET, Despres JP, Marcotte M, et al. Genotype-dependency of adaptation in adipose tissue metabolism after short-term overfeeding. Am J Physiol, 1986, 250, E480-E485.
83. Mauriege P, Despres JP, Marcotte M, et al. Adipose tissue lipolysis after long-term overfeeding in identical twins. Int J Obesity, 1992, 16, 219-225.
84. Hellström L, Langin D, Reynisdottir S, Dauzats M, Arner P. Adipocyte lipolysis in normal weight subjects with obesity among firstdegree relatives. Diabetologia. 1996, 39, 921-928.
85. Shimada F. Makino H, Hashimoto N, et al. Detection of an amino acid polymorphism in hormone-sensitive lipase in Japanese subjects. Metabolism, 1996, 45, 862-864.
86. Magre J, Laurell H, Fizames C, et al. Human hormone-sensitive lipase. Genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes, 1998, 47, 284-286.
87. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med, 1995, 333, 348-351.
88. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med, 1995, 333, 352-354.
89. Li LS, Lönnqvist F, Luthman H, Arner P. Phenotypic characterisation of the Thrp64Arg polymorphism in the β3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia, 1996, 39, 857-860.
90. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Ericksson P, Lannfelt L, Arner P. Human β-2 adrenoceptor gene polymorphism are highly frequent in obesity and associate with altered adipocyte β-2 adrenoceptor function. J Clin Invest, 1997, 100, 3005-3013.
91. Clausen JO, Hansen T, Björbaek C, et al. Insulin resistance : interactions between obesity and a common variant of insulin receptor substrate-1. Lancet, 1995, 346, 391-401.